Koyfin Home > Directory > Health Care > Arena Pharmaceuticals > Long-Term Debt / Capital

Arena Pharmaceuticals Long-Term Debt / Capital Chart (ARNA)

Arena Pharmaceuticals annual/quarterly Long-Term Debt / Capital from 2000 to 2018.
  • Arena Pharmaceuticals Long-Term Debt / Capital for the quarter ending December 12, 2018 was $8m a -16.94% decrease of -1m year over year
  • Arena Pharmaceuticals Long-Term Debt / Capital for the last 12 months ending December 12, 2018 was $8m a -16.94% decrease of -1m year over year
  • Arena Pharmaceuticals Annual Long-Term Debt / Capital for 2018 was $8m a -162.55% decrease of -13m from 2017
  • Arena Pharmaceuticals Annual Long-Term Debt / Capital for 2017 was $21m a -172.11% decrease of -37m from 2016
  • Arena Pharmaceuticals Annual Long-Term Debt / Capital for 2016 was $58m a 8.30% increase of 5m from 2015
Other Ratios Metrics:
  • Arena Pharmaceuticals Total Debt / Capital for the quarter ending September 09, 2018 was $10m a -127.22% decrease of -13m year over year
  • Arena Pharmaceuticals Other Liabilities for the quarter ending September 09, 2018 was $1m a -69.22% decrease of -1m year over year
  • Arena Pharmaceuticals Total Debt / Equity for the quarter ending September 09, 2018 was $11m a -165.14% decrease of -19m year over year
View Chart On Koyfin

Quarterly ARNA Long-Term Debt / Capital Data

12/2018$8m
09/2018$10m
06/2018$10m
03/2018$10m
12/2017$21m
09/2017$21m
06/2017$41m
03/2017$67m
12/2016$58m
09/2016$89m

Annual ARNA Long-Term Debt / Capital Data

2018$8m
2017$21m
2016$58m
2015$54m
2014$58m
2013$43m
2012$42m
2011$88m
2010$50m
2009$65m